The letter

One letter a week, starting soon.

The week's signal, what shipped, what is worth running tonight, and the editor's note. No tracking, no ads, nothing else.

We keep your address, your language and the date you joined, nothing else. Every letter has a one-click unsubscribe link that deletes the record.

← Accept All   Archive
Tech.euEurope

Vale Biolabs receives €164K from Venture Kick to advance brain disease research

11.09

Biotech startup Vale Biolabs has received €164,000 (CHF 150,000) from Venture Kick to advance its platform for studying brain diseases and evaluating potential treatments.

Read at Tech.eu ↗

More from Tech.eu on Accept All

More from Tech.eu on Accept All.